Logo image of DRW8.DE

DRAEGERWERK AG (DRW8.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:DRW8 - DE0005550602 - Common Stock

62.4 EUR
-1.2 (-1.89%)
Last: 11/28/2025, 7:00:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to DRW8. DRW8 was compared to 63 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of DRW8 get a neutral evaluation. Nothing too spectacular is happening here. DRW8 may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

DRW8 had positive earnings in the past year.
DRW8 had a positive operating cash flow in the past year.
DRW8 had positive earnings in 4 of the past 5 years.
Of the past 5 years DRW8 4 years had a positive operating cash flow.
DRW8.DE Yearly Net Income VS EBIT VS OCF VS FCFDRW8.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

With a decent Return On Assets value of 3.99%, DRW8 is doing good in the industry, outperforming 60.32% of the companies in the same industry.
DRW8 has a Return On Equity (8.02%) which is comparable to the rest of the industry.
DRW8 has a Return On Invested Capital of 7.67%. This is in the better half of the industry: DRW8 outperforms 69.84% of its industry peers.
Industry RankSector Rank
ROA 3.99%
ROE 8.02%
ROIC 7.67%
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
DRW8.DE Yearly ROA, ROE, ROICDRW8.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 3.54%, DRW8 is in line with its industry, outperforming 46.03% of the companies in the same industry.
DRW8's Profit Margin has improved in the last couple of years.
DRW8 has a worse Operating Margin (6.02%) than 60.32% of its industry peers.
In the last couple of years the Operating Margin of DRW8 has grown nicely.
DRW8 has a worse Gross Margin (45.35%) than 65.08% of its industry peers.
DRW8's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.02%
PM (TTM) 3.54%
GM 45.35%
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
DRW8.DE Yearly Profit, Operating, Gross MarginsDRW8.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DRW8 is creating some value.
DRW8 has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, DRW8 has more shares outstanding
Compared to 1 year ago, DRW8 has an improved debt to assets ratio.
DRW8.DE Yearly Shares OutstandingDRW8.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
DRW8.DE Yearly Total Debt VS Total AssetsDRW8.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 2.69 indicates that DRW8 is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of DRW8 (2.69) is comparable to the rest of the industry.
DRW8 has a debt to FCF ratio of 2.16. This is a good value and a sign of high solvency as DRW8 would need 2.16 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 2.16, DRW8 belongs to the best of the industry, outperforming 80.95% of the companies in the same industry.
DRW8 has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of DRW8 (0.10) is better than 76.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 2.16
Altman-Z 2.69
ROIC/WACC1.16
WACC6.62%
DRW8.DE Yearly LT Debt VS Equity VS FCFDRW8.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

DRW8 has a Current Ratio of 1.76. This is a normal value and indicates that DRW8 is financially healthy and should not expect problems in meeting its short term obligations.
DRW8 has a Current ratio of 1.76. This is comparable to the rest of the industry: DRW8 outperforms 57.14% of its industry peers.
A Quick Ratio of 1.03 indicates that DRW8 should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.03, DRW8 is in line with its industry, outperforming 44.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.03
DRW8.DE Yearly Current Assets VS Current LiabilitesDRW8.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

DRW8 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.68%.
DRW8 shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 36.42% yearly.
The Revenue has been growing slightly by 2.14% in the past year.
The Revenue has been growing slightly by 3.92% on average over the past years.
EPS 1Y (TTM)6.68%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%143.82%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%7.58%

3.2 Future

The Earnings Per Share is expected to grow by 7.93% on average over the next years.
Based on estimates for the next years, DRW8 will show a small growth in Revenue. The Revenue will grow by 3.15% on average per year.
EPS Next Y5.11%
EPS Next 2Y10.82%
EPS Next 3Y11.88%
EPS Next 5Y7.93%
Revenue Next Year2.9%
Revenue Next 2Y3.54%
Revenue Next 3Y3.68%
Revenue Next 5Y3.15%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
DRW8.DE Yearly Revenue VS EstimatesDRW8.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B
DRW8.DE Yearly EPS VS EstimatesDRW8.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.67, the valuation of DRW8 can be described as very reasonable.
DRW8's Price/Earnings ratio is rather cheap when compared to the industry. DRW8 is cheaper than 98.41% of the companies in the same industry.
When comparing the Price/Earnings ratio of DRW8 to the average of the S&P500 Index (26.31), we can say DRW8 is valued rather cheaply.
DRW8 is valuated reasonably with a Price/Forward Earnings ratio of 8.55.
Based on the Price/Forward Earnings ratio, DRW8 is valued cheaply inside the industry as 93.65% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of DRW8 to the average of the S&P500 Index (36.59), we can say DRW8 is valued rather cheaply.
Industry RankSector Rank
PE 9.67
Fwd PE 8.55
DRW8.DE Price Earnings VS Forward Price EarningsDRW8.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DRW8 indicates a rather cheap valuation: DRW8 is cheaper than 96.83% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DRW8 indicates a rather cheap valuation: DRW8 is cheaper than 98.41% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 8.55
EV/EBITDA 3.47
DRW8.DE Per share dataDRW8.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DRW8 does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)1.89
PEG (5Y)0.27
EPS Next 2Y10.82%
EPS Next 3Y11.88%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.19%, DRW8 has a reasonable but not impressive dividend return.
DRW8's Dividend Yield is rather good when compared to the industry average which is at 2.22. DRW8 pays more dividend than 95.24% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, DRW8 pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.19%

5.2 History

On average, the dividend of DRW8 grows each year by 51.02%, which is quite nice.
Dividend Growth(5Y)51.02%
Div Incr Years2
Div Non Decr Years4
DRW8.DE Yearly Dividends per shareDRW8.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

31.13% of the earnings are spent on dividend by DRW8. This is a low number and sustainable payout ratio.
The dividend of DRW8 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP31.13%
EPS Next 2Y10.82%
EPS Next 3Y11.88%
DRW8.DE Yearly Income VS Free CF VS DividendDRW8.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M
DRW8.DE Dividend Payout.DRW8.DE Dividend Payout, showing the Payout Ratio.DRW8.DE Dividend Payout.PayoutRetained Earnings

DRAEGERWERK AG

FRA:DRW8 (11/28/2025, 7:00:00 PM)

62.4

-1.2 (-1.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-29 2025-10-29
Earnings (Next)03-24 2026-03-24
Inst Owners10.49%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.17B
Revenue(TTM)3.42B
Net Income(TTM)120.88M
Analysts78.67
Price Target82.49 (32.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.19%
Yearly Dividend1.77
Dividend Growth(5Y)51.02%
DP31.13%
Div Incr Years2
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)11.47%
PT rev (3m)13.55%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.39%
EPS NY rev (3m)2.21%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)-0.39%
Valuation
Industry RankSector Rank
PE 9.67
Fwd PE 8.55
P/S 0.34
P/FCF 8.55
P/OCF 5.77
P/B 0.78
P/tB 1
EV/EBITDA 3.47
EPS(TTM)6.45
EY10.34%
EPS(NY)7.3
Fwd EY11.7%
FCF(TTM)7.29
FCFY11.69%
OCF(TTM)10.82
OCFY17.34%
SpS182.27
BVpS80.37
TBVpS62.21
PEG (NY)1.89
PEG (5Y)0.27
Graham Number108
Profitability
Industry RankSector Rank
ROA 3.99%
ROE 8.02%
ROCE 10.2%
ROIC 7.67%
ROICexc 8.64%
ROICexgc 10.67%
OM 6.02%
PM (TTM) 3.54%
GM 45.35%
FCFM 4%
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-18.01%
ROICexgc growth 5Y12.44%
ROICexc growth 3Y-16.98%
ROICexc growth 5Y13.06%
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
F-Score7
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 2.16
Debt/EBITDA 0.44
Cap/Depr 44.92%
Cap/Sales 1.93%
Interest Coverage 11.48
Cash Conversion 57.51%
Profit Quality 113.22%
Current Ratio 1.76
Quick Ratio 1.03
Altman-Z 2.69
F-Score7
WACC6.62%
ROIC/WACC1.16
Cap/Depr(3y)46.64%
Cap/Depr(5y)59.31%
Cap/Sales(3y)2.11%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.68%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%143.82%
EPS Next Y5.11%
EPS Next 2Y10.82%
EPS Next 3Y11.88%
EPS Next 5Y7.93%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%7.58%
Revenue Next Year2.9%
Revenue Next 2Y3.54%
Revenue Next 3Y3.68%
Revenue Next 5Y3.15%
EBIT growth 1Y12.74%
EBIT growth 3Y-13.63%
EBIT growth 5Y16.27%
EBIT Next Year81.51%
EBIT Next 3Y29.6%
EBIT Next 5Y13.49%
FCF growth 1Y20.52%
FCF growth 3Y-27.65%
FCF growth 5Y0.28%
OCF growth 1Y11.8%
OCF growth 3Y-24.25%
OCF growth 5Y0.35%

DRAEGERWERK AG / DRW8.DE FAQ

Can you provide the ChartMill fundamental rating for DRAEGERWERK AG?

ChartMill assigns a fundamental rating of 5 / 10 to DRW8.DE.


What is the valuation status for DRW8 stock?

ChartMill assigns a valuation rating of 7 / 10 to DRAEGERWERK AG (DRW8.DE). This can be considered as Undervalued.


What is the profitability of DRW8 stock?

DRAEGERWERK AG (DRW8.DE) has a profitability rating of 4 / 10.


What are the PE and PB ratios of DRAEGERWERK AG (DRW8.DE) stock?

The Price/Earnings (PE) ratio for DRAEGERWERK AG (DRW8.DE) is 9.67 and the Price/Book (PB) ratio is 0.78.


Can you provide the expected EPS growth for DRW8 stock?

The Earnings per Share (EPS) of DRAEGERWERK AG (DRW8.DE) is expected to grow by 5.11% in the next year.